Dietary supplement shows promise for diabetic foot ulcers
NCT ID NCT07442110
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a special dietary supplement could help heal foot ulcers in people with diabetes and prevent the need for amputation. 35 adults with diabetes and foot ulcers were observed for 6 weeks while using the supplement at home. The main goals were to see how many ulcers fully healed and how many amputations were avoided.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
35 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of 35 adult patients (both male and female) diagnosed with Type 1 or Type 2 Diabetes Mellitus who present with chronic, unhealed diabetic foot ulcers (Wagner Stages 1 to 5). This group includes high-risk individuals who have previously undergone minor amputations (e.g., toe/digit) or were clinically scheduled for lower extremity amputations due to failed standard wound care. The participants are observed in an at-home setting, where they self-administer the specialized dietary supplement protocol.
- Ages
-
25 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Diagnosis of Type 1 or Type 2 Diabetes Mellitus. Presence of at least one chronic diabetic foot ulcer (DFU) classified as Wagner Grade 1 to 5. Patients currently facing potential lower extremity amputation as recommended by a surgical consultation. Patients currently adhering to the specific dietary supplements protocol for wound healing. Ability to participate in a 6-week clinical observation period with weekly monitoring. Age 18 years and older. Exclusion Criteria Patients with non-diabetic ulcers (e.g., pressure sores not related to diabetes or purely venous stasis ulcers). Pregnancy or breastfeeding. Exclusion Criteria: Pregnant women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for At home setting are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amar hocine Zireg
Bordj Bou Arreridj, Wilaya de Bordj Bou Arréridj, 34000, Algeria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Suction device vs gauze: race to heal open wounds
- Gene therapy shots aim to save legs from amputation in diabetes
- New wound dressing put to the test against diabetic foot ulcers
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- A dissolvable dressing that leaches steroid into healing sinuses